Stephen C. Glover - May 18, 2023 Form 4 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Stephen Glover
Stock symbol
AMAM
Transactions as of
May 18, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 08:20 PM
Previous filing
Dec 13, 2022
Next filing
Jul 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMAM Stock Option (right to buy) Award $0 +210K $0.00 210K May 18, 2023 Ordinary Shares 210K $1.97 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the options is equal to the fair market value per ordinary share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").
F2 The Ordinary Shares subject to the option vest in thirty-six (36) equal monthly installments following May 19, 2023.
F3 The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven (7) Ordinary Shares of the Issuer.